Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-25 4:56 pm Purchase | 2023-09-14 | 13G | Disc Medicine, Inc. IRON | Paradigm BioCapital Advisors LP | 1,235,918 5.400% | 1,235,918 (New Position) | Filing History |
| 2023-09-13 5:22 pm Purchase | 2023-09-12 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 7,803,600 14.300% | 5,288,489 (+210.27%) | Filing History |
| 2023-07-21 4:44 pm Purchase | 2023-07-11 | 13G | Arcellx, Inc. ACLX | Paradigm BioCapital Advisors LP | 2,422,700 5.050% | 2,422,700 (New Position) | Filing History |
| 2023-07-10 5:00 pm Purchase | 2023-06-30 | 13G | Autolus Therapeutics plc AUTL | Paradigm BioCapital Advisors LP | 10,098,584 5.800% | 10,098,584 (New Position) | Filing History |
| 2023-05-11 4:26 pm Purchase | 2023-05-01 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 2,310,698 5.400% | 419,531 (+22.18%) | Filing History |
| 2023-04-10 4:33 pm Purchase | 2023-03-29 | 13G | Olema Pharmaceuticals, Inc. OLMA | Paradigm BioCapital Advisors LP | 2,515,111 6.200% | 2,515,111 (New Position) | Filing History |
| 2023-02-24 4:54 pm Purchase | 2023-02-14 | 13G | Bicycle Therapeutics plc BCYC | Paradigm BioCapital Advisors LP | 1,610,665 5.400% | 1,610,665 (New Position) | Filing History |
| 2023-02-14 4:59 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 1,891,167 4.700% | 682,116 (+56.42%) | Filing History |
| 2023-02-14 4:59 pm Sale | 2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST | Paradigm BioCapital Advisors LP | 0 0.000% | -1,462,576 (Position Closed) | Filing History |
| 2023-02-14 4:58 pm Purchase | 2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Paradigm BioCapital Advisors LP | 2,317,634 5.050% | 102,912 (+4.65%) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Vor Biopharma Inc. VOR | Paradigm BioCapital Advisors LP | 6,477,999 9.900% | 4,149,505 (+178.21%) | Filing History |
| 2022-10-27 4:47 pm Purchase | 2022-10-17 | 13G | Vor Biopharma Inc. VOR | Paradigm BioCapital Advisors LP | 2,328,494 6.100% | 2,328,494 (New Position) | Filing History |
| 2022-10-03 5:16 pm Purchase | 2022-09-23 | 13G | Alpine Immune Sciences, Inc. ALPN | Paradigm BioCapital Advisors LP | 2,214,722 5.030% | 2,214,722 (New Position) | Filing History |
| 2022-07-18 4:24 pm Purchase | 2022-07-07 | 13G | Oyster Point Pharma, Inc. OYST | Paradigm BioCapital Advisors LP | 1,462,576 5.500% | 1,462,576 (New Position) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Paradigm BioCapital Advisors LP | 1,209,051 5.570% | 1,209,051 (New Position) | Filing History |